Concentric Capital Strategies, LP Teva Pharmaceutical Industries LTD Transaction History
Concentric Capital Strategies, LP
- $1.94 Billion
- Q2 2024
A detailed history of Concentric Capital Strategies, LP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Concentric Capital Strategies, LP holds 75,856 shares of TEVA stock, worth $1.4 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
75,856Holding current value
$1.4 Million% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding TEVA
# of Institutions
612Shares Held
569MCall Options Held
25.2MPut Options Held
5.08M-
Black Rock Inc. New York, NY43MShares$793 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.3MShares$670 Million41.14% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L332.3MShares$597 Million5.5% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.29.1MShares$537 Million7.9% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$532 Million3.23% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $20.5B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...